Global X HealthTech ETF

BTIG Analyst Maintains Buy Rating on Intuitive Surgical

Alibaba's ATH Innovation Department's AI Model HappyHorse to Soon Open API

ResMed CEO Michael Farrell Sells Company Stock

Goldman Sachs Downgrades Alibaba Health's Target Price to HKD 4.8

Citigroup Analyst Maintains Buy Rating on ResMed

Citi Sees ResMed Q3 FY2026 Revenue at $1.44B but Margins Cut

CLSA Downgrades Alibaba Health's Profit Forecast and Target Price

Intuitive Surgical Consensus Recommended as Moderate Buy by Analysts

GE HealthCare Announces Leadership in EU Cardiac Oncology Care Initiative

GE HealthCare to Showcase Cardiology Portfolio at ACC.26

Alibaba Health and Novartis Announce Chronic Spontaneous Urticaria Digital Chronic Disease Collaboration

Alignment Healthcare CEO sold 118,000 common stocks

GE HealthCare's Photonova Spectra Photon-counting CT System Receives FDA Clearance and Prepares for Commercial Launch

Brandon Vazquez Reiterates Buy Rating on Intuitive Surgical Stock

Alibaba CEO Wu Y 昺 Launches Enterprise AI-Native Work Platform “Wukong”

GE HealthCare Completes Acquisition of Intelerad for $2.3 Billion

Intuitive Surgical asked by FDA to remove certain staplers from use

Intuitive Surgical Announces 2025 Annual Report, Emphasizing Global Expansion and Digital Functionality

Alibaba Establishes Alibaba Token Hub to Advance AI Strategy

IQVIA Launches IQVIA.AI to Enhance Efficiency in Life Sciences

Fusemachines

Erayak Power Solution

Smart Powerr

Sky Quarry

Cue BioPharma

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

ZeZentalis Pharma

XCF Global

Rackspace Tech

U Power

HEAL

DOCS

LGHT

Goldman Sachs analyst David Roman has maintained a Hold rating on Doximity (DOCS) with a price target of $28.00. Roman, who covers the Healthcare sector, has an average return of -4.9% and a 37.65% success rate on his stock recommendations. Additionally, Evercore ISI's Elizabeth Anderson also issued a Hold rating on Doximity, while TipRanks – xAI reiterated a Buy rating on the stock on the same day.

Tip Ranks

First Trust Nasdaq Lux Digital Health Solutions ETF

Doximity

Langar Global HealthTech ETF

Doximity (DOCS) Gets a Hold from Goldman Sachs

TSLQ

FDHT

EDOC

TDOC

Wall Street saw gains with the S&P 500 up 3.3% this week. Oracle plans to cut 20,000-30,000 jobs to boost cash flow amid AI investments. Tesla delivered 358,023 vehicles, missing estimates, while Nike's guidance disappointed, forecasting a sales decline. Applied Optoelectronics surged 20% after a $71 million order, and Teladoc Health rose 6% amid activist investor pressure for a buyback and strategic review.

- Wall Street closed the trading week on a positive note, driven by a robust March jobs report.  
- The Nasdaq Composite increased by 4.4%, the S&P 500 rose by 3.3%, and the Dow climbed by 2.9%.  
- Geopolitical tensions contributed to rising oil prices, while Oracle is reportedly reducing its workforce significantly.

SPDR S&P 500

AXS TSLA Bear Daily ETF

iShares Core S&P 500

Applied Optoelectronics

T-Rex 2X Long Tesla Daily Target ETF

Fidelity Digital Health ETF

iShares MSCI USA Min Vol Factor ETF

Direxion Daily TSLA Bear 1X Shares

SPDR FD Consumer Discretionary

Ps S&P Low Vol

SPDR S&P Retail ETF

Global X Telemedicine & Digital Health ETF

VanEck Retail ETF

Invesco S&P 500 Eq Wgt ETF

VG S&P 500

Global X Cloud Computing ETF

GraniteShares 1.25 Long TSLA Daily ETF

Teladoc

Invesco Nasdaq Future Gen 200 ETF

GraniteShares 2x Long TSLA Daily ETF

Nike

Defiance Daily Target 2X Long ORCL ETF

Oracle

GraniteShares 2x Short TSLA Daily ETF

Simplify Volt TSLA Revolution ETF

T-Rex 2X Inverse Tesla Daily Target ETF

Global X Nasdaq 100 Covered Call ETF

Leverage Shares 2X Long TSLA Daily ETF

S&P 500

Direxion Daily TSLA Bull 2X Shares

ISHRS S&P Glb It

Tesla

Trending stocks this week as S&P 500 notches best weekly gain in 5 months

Pineal Capital Management is urging Teladoc Health Inc. to enhance shareholder value through buybacks, cost reductions, and a strategic review, citing concerns over its low valuation and potential takeover risks. The firm criticized past acquisitions and the lack of buybacks, noting Teladoc's stock has dropped over 90% since pre-COVID highs. Pineal proposed a three-part strategy to improve performance, highlighting strong fundamentals and growth potential in Teladoc's mental health segment. Despite recent quarterly results exceeding expectations, Teladoc's shares were down 0.64% at $5.52 at the time of publication.

benzinga_article

Teladoc Faces Pressure Over Capital Allocation And Stock Underperformance

Teladoc Adds Susan Salka to Expanded Board of Directors

Teladoc Adds Susan Salka to Expanded Board of Directors

Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform | DOSEF Stock News

StockTitan

Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform | DOSEF Stock News

UberDoc Health Technologies Corp., a digital healthcare marketplace, has gone public on the Canadian Securities Exchange following a successful reverse merger. Founded by Dr. Paula Muto and led by CEO Sean Kearney, UberDoc connects patients with board-certified specialists, emphasizing transparent pricing. The company received a 2026 Dealmakers Award for this achievement, which positions it for growth in the healthcare sector. With operations in Vancouver and Boston, UberDoc aims to enhance patient access to care while providing physicians with greater control over their practices.

UberDoc Honored for Reverse Merger as Healthcare Marketplace Goes Public on CSE

Welldoc® has been awarded the 2026 Artificial Intelligence Excellence Award by the Business Intelligence Group, marking its third consecutive win in the Health Product category. This recognition highlights Welldoc's leadership in healthcare-ready AI, which combines clinical precision with regulated capabilities to provide personalized insights for individuals and healthcare organizations. The company aims to enhance health outcomes through innovative, evidence-based support programs and has been acknowledged as an early adopter in the CMS Health Tech Ecosystem Initiative.

MorningStar

Welldoc® Honored with 2026 Artificial Intelligence Excellence Award

ARTY

BMED

Sage Growth Partners released a report indicating that C-suites in healthcare anticipate declining capital investments for 2026-2027. Despite this, they are prioritizing investments in AI, data analytics, and patient engagement technologies. Key findings show that 41% expect reduced capital investments, while 57% rank AI-based clinical solutions as a top initiative. The focus is shifting towards initiatives that drive growth, such as patient acquisition and expanding into new markets. C-suite leaders are looking for health IT companies to demonstrate cost savings and align digital strategies with financial goals.

prnewswire

iShares Future AI & Tech ETF

Blackrock Future Health ETF

SPDR S&P Software

iShares Expanded Tech Software Sector ETF

Global X Funds Global X Artificial Intelligence & Tech ETF

08:52 ETNew Health IT Purchasing Forecast Report from Sage Growth Partners Reveals C-Suites' Health IT Investment Plans for 2026-2027

MDEV

CODX

A recent market research report by Vyansa Intelligence revealed that the Global Diagnostic Labs Market is anticipated to experience a steady growth, with a projected compound annual growth rate (CAGR) of approximately 6.66% between 2026 and 2032. This growth is mainly attributed to the rising need for early diagnostic services.

Unusual Whales

First Trust Indxx Medical Devices ETF

Co-Diagnostics

ALPS Medical Breakthrough

VanEck Biotech ETF

Health Care Select Sector SPDR

Bluejay Diagnostics

First Trust NYSE Arca Biotech Index Fd

iShares Genomics Immunology and Healthcare ETF

iShares US Medical Devices

SPDR S&P Biotech

SPDR S&P Health Equip

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

ROBO Global Healthcare Tech and Innovation ETF

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Global Diagnostic Labs Market to Grow at a CAGR of 6.66%, Reaching USD 223 Billion by 2032, Reports Vyansa Intelligence

Doximity's recent study reveals that 94% of physicians are using or interested in AI, yet 71% express concerns about its accuracy. The report indicates a significant rise in AI adoption among physicians, with 54% currently using it, and 37% using it daily. Key applications include literature searches and voice-based documentation. The majority of AI users report reduced administrative burdens and improved job satisfaction, with 90% believing AI can alleviate after-hours work contributing to burnout. Doximity, a leading platform for U.S. medical professionals, emphasizes the importance of accuracy and physician involvement in AI development.

Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist | DOCS Stock News

520880

159883

At the ATTD 2026, AI has emerged as a key topic in diabetes care. SIBIONICS introduced AI-driven features that transform everyday data into actionable insights, enhancing continuous glucose monitoring (CGM) beyond mere tracking. Innovations include multi-day time in range (TIR) overviews and intelligent logging for better glucose pattern recognition. Healthcare professionals emphasize the importance of personalized AI tools that convert complex data into clear recommendations, supporting patient engagement and clinical decision-making. The symposium featured experts discussing advancements in diabetes technology and the evolving role of AI in improving diabetes management.

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

iShares US Healthcare Providers

Bosera Hang Seng SCHK Innovative Drug Select ETF

Beta Bionics

VG Health

Tandem Diabetes

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Fidelity Disruptive Medicine ETF

Novo Nordisk AS

China Universal 800 Health Care ETF

Guotai SSE STAR Brand Name Drug ETF

ICBCCS SSE STAR Biology and Medicine ETF

E Fund CSI 300 Health Care ETF

iShares Global Healthcare

China Merchants CSI Biotechnology Theme ETF

Ping An CSI Medicine and Medical Device Innovation ETF

YUYUE MEDICAL

Invesco Nasdaq Biotechnology ETF

Guotai CSI Bio-medicine ETF

E Fund CSI Biotechnology Theme ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Direxion Daily Robotics AI & Auto Bull 2X

Dacheng CSI All Share Health Care Equipment and Services ETF

SPDR S&P Health

Bosera Hang Seng Health Care ETF(QDII)

ChinaAMC SSE Health Care ETF Initiating Fund

Minsheng Royal CSI Biotechnology Theme ETF

ChinaAMC CSI All Share Health Care Devices ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

E Fund Hang Seng SCHK Innovative Drug ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Huaan Hang Seng Biotech ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

COFOE

Defiance Daily Target 2X Long NVO ETF

Penghua SSE STAR Biology and Medicine ETF

SI-BONE

Tianhong CNI BIOMEDICINE ETF

Direxion Healthcare Bull 3X

Ark Genomic Revolution ETF

Yinhua CSI Innovative Drugs Industry ETF

Sinocare

China Merchants CSI All Share Medical Apparatus and Instruments ETF

iShares US Pharma

China Southern Hang Seng Biotech ETF(QDII)

00:57 ETATTD Spotlight: Von Blutzuckerwerten zu KI-basierten Erkenntnissen - eine neue Richtung für das Diabetes-Management

Capital Fund Management S.A. increased its stake in Doximity, Inc. (NYSE:DOCS) by 252% in Q3, acquiring 108,937 shares, bringing its total to 152,173 shares valued at $11.13 million. Other institutional investors also raised their holdings. Doximity's stock opened at $24.22, with a market cap of $4.47 billion. The company reported a 9.8% revenue increase year-over-year and announced a $500 million stock buyback program. Analysts have mixed ratings, with price targets ranging from $34 to $55.

Market Beat

Capital Fund Management S.A. Acquires 108,937 Shares of Doximity, Inc. $DOCS

Labcorp Holdings Inc. (LH) shares fell 2.78% to $262.91 on a poor trading day, while the S&P 500 and Dow Jones also declined. Despite this, Labcorp's performance was better than some competitors, with IQVIA down 5.04%, Centene down 3.60%, and Teladoc down 2.01%. Labcorp remains 10.49% below its 52-week high of $293.72 reached on October 21st. Trading volume was 734,820, surpassing the 50-day average of 715,209.

Dow Jones

Centene

IQVIA

Labcorp

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

ATNF

Restart Life Sciences is leveraging its certified Holy Crap manufacturing facility to scale its functional wellness brands. The facility holds multiple certifications, allowing for a premium production platform that reduces costs and improves margins. Restart Life is collaborating with the University of Manitoba for product development and has granted 1,000,000 restricted share units to consultants. Stuhini Exploration (TSE:NOVA) has a Hold rating with a C$0.22 price target, facing challenges like no revenue and persistent losses, but has favorable technicals and a low-debt balance sheet.

180 Life Sciences

ReShape Lifesciences

Restart Life Leverages Certified Plant to Scale Functional Wellness Brands

Teladoc Health shares are trading higher after Deutsche Bank upgraded the stock from Hold to Buy rating and announced a $11 price target.

Global X HealthTech ETF(HEAL.US)

Global X HealthTech ETF Stock Performance Chart

Doximity (DOCS) Gets a Hold from Goldman Sachs

Trending stocks this week as S&P 500 notches best weekly gain in 5 months

Teladoc Faces Pressure Over Capital Allocation And Stock Underperformance

Teladoc Adds Susan Salka to Expanded Board of Directors

Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform | DOSEF Stock News